MarketsandMarkets: Global Oncology Biomarkers Market Worth US$9.5 Billion by 2014

DALLAS, Texas, April 29, 2010 - According to a new market research report, 'global oncology
biomarker market', published by MarketsandMarkets
(www.marketsandmarkets.com), The global oncology biomarker market is
expected to grow from $4.1 billion in 2009 to $9.5 billion in 2014 at a CAGR
of 18.1% from 2009 to 2014. The Global Oncology Biomarkers Market report
analyzes the oncology biomarkers diagnostics and discovery market over the
period 2009-2014. The report studies the major market drivers, restraints,
and opportunities for the oncology biomarkers market.

Browse more than 45 market data tables and in-depth TOC on Global
Oncology Biomarkers Market. Early buyers will receive 10% customization of
reports.
www.marketsandmarkets.com/Market-Reports/oncology-biomarkers-202.html

The global oncology biomarker market is expected to grow from $4.1
billion in 2009 to $9.5 billion in 2014 at a CAGR of 18.1% from 2009 to 2014.
The key factors driving the growth of the overall oncology biomarkers market
include the rising prevalence of cancer across the globe; and the early
diagnosis and enhanced testing capabilities biomarkers facilitate. Further,
U.S. government initiatives and increasing patient awareness are also
enhancing market growth.

Market players are now focusing on new product and consolidations to
enhance their commercial portfolios. The most common strategies adopted by
market players include agreement and collaborations to stabilize management
costs and to take advantage of the core competencies of the partner company.

SCOPE AND FORMAT

The report analyzes the Oncology biomarkers market into the following
segments:

    - Oncology biomarkers discovery market
    - Oncology biomarkers diagnostics market

The market data consists of aggregate sales figures of all oncology
biomarkers submarkets. It analyzes the market aspects of products and
services; sourcing key market developments from the top companies that it
profiles.

Analyst Briefing Presentation on the Global Oncology Biomarkers Market to
Be Held On 18th May 2010

The Healthcare practice at MarketsandMarkets is pleased to announce
its Analyst Briefing Presentation on the Global oncology biomarkers market
(www.marketsandmarkets.com/Market-Reports/oncology-biomarkers-202.html)
to be held on 18th May 2010. The briefing on the Global Oncology
Biomarkers market (2009-2014) will benefit the biomarker technology
providers, biopharma associations and forums and pharmaceutical companies.

To register your participation, please click here
www.marketsandmarkets.com/AnalystBriefing/oncology-biomarker
-market.asp

(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL address field. Remove the
space if one exists.)

About us

MarketsandMarkets (M&M) is a global market research and consulting
company based in the U.S. We publish strategically analyzed market research
reports and serve as a business intelligence partner to Fortune 500 companies
across the world. MarketsandMarkets also provides multi-client reports,
company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials,
automotive and transportation, banking and financial services, biotechnology,
chemicals, consumer goods energy and power, food and beverages, industrial
automation, medical devices, pharmaceuticals, semiconductor and electronics,
and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by
providing apt business insight with our huge market intelligence repository.
To know more about us and our reports, please visit our website
www.marketsandmarkets.com

    Contact:
    Ms. Sunita
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    Email: sales@marketsandmarkets.com
    www.marketsandmarkets.com

Contact: Ms. Sunita, 7557 Rambler road, Suite 727, Dallas, TX 75231, Tel: +1-888-989-8004, Email: sales at marketsandmarkets.com